Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates
- 13 November 2006
- Vol. 360 (1) , 36-49
- https://doi.org/10.1016/j.virol.2006.10.026
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Priming with Plasmid DNAs Expressing Interleukin-12 and Simian Immunodeficiency Virus Gag Enhances the Immunogenicity and Efficacy of an Experimental AIDS Vaccine Based on Recombinant Vesicular Stomatitis VirusAIDS Research and Human Retroviruses, 2005
- Fitness Analyses of Vesicular Stomatitis Strains with Rearranged Genomes Reveal Replicative DisadvantagesJournal of Virology, 2004
- Immunogenicity of Attenuated Vesicular Stomatitis Virus Vectors Expressing HIV Type 1 Env and SIV Gag Proteins: Comparison of Intranasal and Intramuscular Vaccination RoutesAIDS Research and Human Retroviruses, 2004
- Complete Protection from Papillomavirus Challenge after a Single Vaccination with a Vesicular Stomatitis Virus Vector Expressing High Levels of L1 ProteinJournal of Virology, 2004
- Vesicular Stomatitis Viruses with Rearranged Genomes Have Altered Invasiveness and Neuropathogenesis in MiceJournal of Virology, 2003
- Intranasal Vaccination with a Recombinant Vesicular Stomatitis Virus Expressing Cottontail Rabbit Papillomavirus L1 Protein Provides Complete Protection against Papillomavirus-Induced DiseaseJournal of Virology, 2002
- Replication-Competent or Attenuated, Nonpropagating Vesicular Stomatitis Viruses Expressing Respiratory Syncytial Virus (RSV) Antigens Protect Mice against RSV ChallengeJournal of Virology, 2001
- Laboratory Tests for Live Attenuated Poliovirus VaccinesBiologicals, 1997
- Monkey Neurovirulence Test for Live Mumps VaccineBiologicals, 1996
- Detection of vesicular stomatitis virus (VSV) RNA in the central nervous system of infected mice by in situ hybridizationActa Neuropathologica, 1988